Sutter Health, which co-led the study of the first all-in-one COVID-19 molecular test, is gearing up to offer the test to qualified patients in the next two months after the U.S. Food and Drug Administration granted Emergency Use Authorization.
Learn how the enhanced curriculum in Human Behavior & Mental Health puts Sutter’s Family Medicine Residency Program on a fast-track toward health equity.
As the race to develop a safe and effective vaccine for COVID-19 continues, it may be difficult to understand the terminology used in news reports about the immune system and its response to viruses and vaccines. We’ve summarized some relevant information to help keep you updated on the latest COVID-19 vaccine research.
During the current pandemic, it may be difficult to keep pace with the rapid developments in tests, treatments and vaccines being studied for potential widespread use as approved technologies and therapies. You might read these news reports and wonder what is a “Phase 3 clinical trial” or an “emergency use authorization,” and why are these stages of approval by the U.S. Food and Drug Administration (FDA) important? Read on for explanations of common regulatory terms and phrases to help you understand medical research news.
Researchers at Sutter lead a national study to test whether a simple, home-based approach may prevent fractures for those with Parkinson’s disease.
A new study launching at Sutter’s California Pacific Medical Center (CPMC) will use antibody tests to identify front-line doctors who have developed antibodies against the virus. Antibody tests (also called “serology tests” because they use blood samples) are used to determine if someone is producing antibodies to defend against the virus. “A powerful way to …
Sutter participates in international HIV prevention study of cabotegravir, bringing new science to advance care at East Bay Advanced Care.
Testing is conducted to diagnose, understand and help prevent the spread of SARS-CoV-2/novel coronavirus. Follow our Educational Series on testing to stay abreast of the latest updates at Sutter. In Part 2 of this series, we describe antibody tests for SARS-CoV-2.
Shining Light on Mental Health: Research at Sutter Helps Reimagine the Future of Mental Health for At-risk Youth
As the novel coronavirus pandemic ushers in uncertainty that may evoke anxiety, depression or other mental health concerns for today’s youth, what would a new vision for their mental health look like? New screening tools for early detection of severe depression and suicide risk, as well as a novel program called Youth Mental Health Reimagined may be part of the path forward.
Follow our Educational Series on testing to learn about polymerase chain reaction (PCR) and serology testing, and stay abreast of the latest updates at Sutter. In Part 1 of this series, we describe SARS-CoV-2 testing with PCR.